Preclinical Pharmacological Evaluation of a Novel Multiple Kinase Inhibitor, ON123300, in Brain Tumor Models Article

Zhang, Xiaoping, Lv, Hua, Zhou, Qingyu et al. (2014). Preclinical Pharmacological Evaluation of a Novel Multiple Kinase Inhibitor, ON123300, in Brain Tumor Models . MOLECULAR CANCER THERAPEUTICS, 13(5), 1105-1116. 10.1158/1535-7163.MCT-13-0847

Open Access

cited authors

  • Zhang, Xiaoping; Lv, Hua; Zhou, Qingyu; Elkholi, Rana; Chipuk, Jerry E; Reddy, MV Ramana; Reddy, E Premkumar; Gallo, James M

sustainable development goals

authors

publication date

  • May 1, 2014

published in

keywords

  • DOSING REGIMENS
  • GLIOBLASTOMA
  • GLIOMA-CELLS
  • GROWTH
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMA
  • Oncology
  • PDGF RECEPTORS
  • PHARMACODYNAMIC EVALUATION
  • PHASE-I
  • SIGNALING PATHWAYS
  • SOLID TUMORS
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 1105

end page

  • 1116

volume

  • 13

issue

  • 5